Spelling suggestions: "subject:"nitroalkanes"" "subject:"nitroalkane""
1 |
Investigation of the Franck-Condon region photodissociation dynamics of linear and cyclic nitroalkanes using resonance Raman spectroscopy洪美思, Hung, Mei-sze. January 1998 (has links)
published_or_final_version / Chemistry / Master / Master of Philosophy
|
2 |
Investigation of the Franck-Condon region photodissociation dynamics of linear and cyclic nitroalkanes using resonance Raman spectroscopy /Hung, Mei-sze. January 1998 (has links)
Thesis (M. Phil.)--University of Hong Kong, 1998. / Includes bibliographical references (leaves 86-88).
|
3 |
Phase equilibria in nitroparaffin-hydrocarbon systemsHwa, Stephen Chi Ping 08 1900 (has links)
No description available.
|
4 |
Vapor-liquid equilibria in nitroparaffin-hydrocarbon systems which exhibit partial miscibilityEdwards, James Byrd 08 1900 (has links)
No description available.
|
5 |
On the Biochemistry, Mechanism and Physiological Role of Fungal Nitronate MonooxygenaseFrancis, Kevin 27 April 2011 (has links)
Nitronate monooxygenase (E.C. 1.13.11.16), formerly known as 2-nitropropane dioxygenase (EC 1.13.11.32), is a flavin dependent enzyme that catalyzes the oxidation of nitronates to their corresponding carbonyl compounds and nitrite. Despite the fact that the enzyme was first isolated from Neurospora crassa 60 years ago, the biochemical and physiological properties of nitronate monooxygenase have remained largely elusive. This dissertation will present the work that established both the catalytic mechanism and physiological role of the fungal enzyme.
The biological and biochemical properties of propionate-3-nitronate, the recently discovered physiological substrate for nitronate monooxygenase, will be extensively reviewed. The nitronate is produced by a variety of variety leguminous plants and fungi and is a potent and irreversible inhibitor of succinate dehydrogenase. Nitronate monooxygenase allows N. crassa to overcome the toxicity of propionate-3-nitronate as demonstrated by in vivo studies of the yeast, which showed that the wild-type can grow in the presence of the toxin whereas a knock out mutant that lacks the gene encoding for the enzyme could not.
In addition to establishing the physiological role of nitronate monooxygenase, the work presented here demonstrates that the catalytic mechanism of the enzyme involves the formation of an anionic flavosemiquinone intermediate. This intermediate is stabilized by the protonated form of an active site histidine residue (His-196) that acts as an electrostatic catalyst for the reaction as demonstrated by pH studies of the reductive half reaction of the enzyme. Histidine 196 also serves as the catalytic base for the reaction of the enzyme with nitroethane as substrate as revealed through mutagenesis studies in which the residue was replaced with an asparagine.
The kinetic implications of branching of reaction intermediates in enzymatic catalysis are also demonstrated through studies of the kinetic isotope effects of nitronate monooxygenase with 1,1-[2H2]-nitroethane as substrate. Finally the use of competitive inhibitors as a probe of enzyme structure will be presented through a study of the inhibition of nitronate monooxygenase with mono-valent inorganic ions. The dissertation will close with unpublished work on the enzyme and concluding remarks concerning the biochemistry and physiology of nitronate monooxygenase.
|
Page generated in 0.0427 seconds